ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
AI startup Evvy has closed a $40 million Series B funding round to scale its precision diagnostics platform for women's health. The round was led by Catalio Capital Management. The company's AI platform, EvvyAI, analyzes vaginal microbiome data from at-home test kits to provide personalized treatment plans, aiming to address high misdiagnosis and recurrence rates in conditions like bacterial vaginosis.
Tap to vote and see what everyone thinks.
Summary by ByteBrief